(Q28285049)

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

PubMed

volume

7

0 references

issue

1

0 references

page(s)

49-58

0 references

cites work

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The cancer epigenome: its origins, contributions to tumorigenesis, and translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Epidemiology of Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The molecular epidemiology of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Molecular predictive and prognostic markers in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Role of tumor markers in patients with solid cancers: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The role of DNA methylation in the development and progression of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Genome-wide DNA methylation profiling of non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Microarray analysis of promoter methylation in lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Comparative DNA methylation analysis in normal and tumour tissues and in cancer cell lines using differential methylation hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Aberrant methylation of the adenomatous polyposis coli promoter 1A in bronchial aspirates from patients with suspected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation based biomarkers in non-invasive cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation‐Sensitive Representational Difference Analysis and Its Application to Cancer Research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Gene promoter methylation in plasma and sputum increases with lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MethMarker: user-friendly design and optimization of gene-specific DNA methylation assays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Defining a gene promoter methylation signature in sputum for lung cancer risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Molecular detection approaches for smoking associated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Differences in the quantity of DNA found in the urine and saliva of smokers versus nonsmokers: implications for the timing of epigenetic events.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation as clinically useful biomarkers-light at the end of the tunnel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Lung cancer: from single-gene methylation to methylome profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation of RAS association domain family protein 1A as a biomarker of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation and nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation markers and early recurrence in stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Impact of EGFR mutation analysis in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Methylation markers of early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

microRNAs join the p53 network--another piece in the tumour-suppression puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

OncomiRs: the discovery and progress of microRNAs in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MicroRNA-206 is associated with invasion and metastasis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

DNA methylation profiling in the clinic: applications and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.111

21 January 2018

Identifiers

DOI

10.2217/BMM.12.111

1 reference

Consolidated OpenCitations Corpus – April 2017

release_ghxzeig7oba7li6xzcevh67xze

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ghxzeig7oba7li6xzcevh67xze

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23387484

1 reference

Consolidated OpenCitations Corpus – April 2017